162 results
Page 5 of 9
424B5
iry oyd7dfcy
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
3to8xkelvrf66a0676p
19 Aug 20
BioLineRx Achieves Enrollment Target in Phase 3
7:08am
POS AM
b0or5
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
6-K
EX-99
xwhzx2ioypqy eomm
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B3
evvav 83fcz
2 Jul 20
Prospectus supplement
4:28pm
F-1
9x4kyjd4
26 Jun 20
Registration statement (foreign)
4:30pm
424B5
c5jubou kkzx5aegimfw
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
6vpn6bkj7uabybu5n3
1 Jun 20
BioLineRx Announces $4.39 Million Registered Direct Offering
8:05am
424B5
gisxd3370 2art4
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
2izv2pijme6k8v
26 May 20
BioLineRx Announces $9.0 Million Registered Direct Offering
8:45am
6-K
EX-99
ffyxkl lso
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-3
amyfx1idwq5s
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-99
wgyu9jl z8
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
f5hlf ske0mr8
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
4ehy1kttexs2ingylm6i
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
60jc3scf
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
hspzbrdd yz9
4 Feb 19
Prospectus supplement for primary offering
5:52pm
F-3
1kuquo zrof9t0px5l
26 Dec 18
Shelf registration (foreign)
4:11pm